Strong association of serum GSK-3 β/BDNF ratio with mild cognitive impairment in elderly type 2 diabetic patients.
CONCLUSION: Our data provide evidence for a strong link between GSK-3β/BDNF ratio and MCI. GSK-3β/BDNF ratio may serve as a better diagnostic biomarker for MD than either GSK-3β or BDNF alone, and increased GSK-3β/BDNF ratio indicates a worse cognitive function.
PMID: 31453785 [PubMed - as supplied by publisher]
Source: Current Alzheimer Research - Category: Neurology Authors: Du B, Lian Y, Chen C, Zhang H, Bi Y, Fan C, Bi X Tags: Curr Alzheimer Res Source Type: research
More News: Alzheimer's | Brain | China Health | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Neurology